TP53 and neoplasm: As previously reflected in this paper, the acquisition of genomic instability associated with telomere shortening is enhanced by TP53 alterations, and the increased telomerase activity in fully established malignant clones is used, perhaps in a designed manner, by tumour cells to their own advantage to increase their survival.